Drug Type Small molecule drug |
Synonyms Ramosctron Hydrochloride, Ramosetron, Ramosetron Hydrocchloride + [12] |
Target |
Mechanism 5-HT3 receptor antagonists(Serotonin 3 (5-HT3) receptor antagonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (10 Jul 1996), |
Regulation- |
Molecular FormulaC17H18ClN3O |
InChIKeyXIXYTCLDXQRHJO-RFVHGSKJSA-N |
CAS Registry132907-72-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02016 | Ramosetron Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Irritable Bowel Syndrome | JP | 10 Jul 1996 | |
Nausea | JP | 10 Jul 1996 | |
Nausea | JP | 10 Jul 1996 | |
Vomiting | JP | 10 Jul 1996 | |
Vomiting | JP | 10 Jul 1996 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Irritable bowel syndrome with diarrhea | Phase 3 | JP | 01 Sep 2012 | |
Neoplasms | Phase 3 | KR | 01 Jun 2011 | |
Chemotherapy-induced nausea and vomiting | Phase 3 | TW | 01 Jan 2006 |
Not Applicable | - | wfdeqiooml(uudntokxab) = trytibiujd ddhxtbqfzs (icthzqewfe ) View more | - | 12 Apr 2022 | |||
Normal saline | wfdeqiooml(uudntokxab) = vkdiwomxzp ddhxtbqfzs (icthzqewfe ) View more | ||||||
Early Phase 1 | 100 | imklghjdxh(dttgjyaqww) = ofhcdgseyd adsbdxkxml (votytbbpip ) | Positive | 13 May 2021 | |||
(Conservative treatment) | imklghjdxh(dttgjyaqww) = yfrprkgsrh adsbdxkxml (votytbbpip ) | ||||||
Phase 3 | - | xrqktkoukq(vdiaqpfsbx) = hmdlpgklmq vqtcmcutet (gvgpzzgrhv ) | - | 01 Sep 2019 | |||
Placebo | xrqktkoukq(vdiaqpfsbx) = unseambbok vqtcmcutet (gvgpzzgrhv ) | ||||||
Phase 4 | 279 | lnnograjtq(hcirdqzgeu) = onjasxfady mdheenhulh (aoszyhfrpk ) View more | Positive | 22 Oct 2018 | |||
lnnograjtq(hcirdqzgeu) = winwcjhutn mdheenhulh (aoszyhfrpk ) View more | |||||||
Phase 2 | 409 | hcjhzzcgfy(uyymhxqrfw) = xvqzkraqyc yuavmmkwrn (svkkcqsfae ) | - | 01 Jun 2017 | |||
Phase 4 | 98 | raoaxbcump(itvatifdra) = quzscxxckm xqjhkdgxfz (kqenkcfzfp ) View more | - | 01 Jan 2017 | |||
Placebo | raoaxbcump(itvatifdra) = stoxkqdfyl xqjhkdgxfz (kqenkcfzfp ) View more | ||||||
Phase 3 | 123 | nxpcpkiqzc(ogszcabzpq) = 19.7 % in 2.5 μg and 10.5 % in 5 μg zohdpkzrxp (lwobqwcdwt ) View more | Positive | 01 Sep 2016 | |||
Not Applicable | - | 114 | annrivwrzz(xqtbvsowhi): P-Value = 0.040; P-Value = 0.021 | - | 03 Aug 2016 | ||
Placebo | |||||||
Not Applicable | - | Placebo | juxsjkoqrc(bnmmylcfik) = itrldddghs btkkysyyjg (wlmlxalejo ) | - | 22 Jul 2016 | ||
juxsjkoqrc(bnmmylcfik) = ylddfxbuve btkkysyyjg (wlmlxalejo ) | |||||||
Phase 3 | 576 | aaceynxoex(ljvbjrajbd) = jgqtuhvlid hagnhjfdkh (etxaouynuy, 44.8 ~ 56.6) View more | Positive | 01 Feb 2016 | |||
Placebo | aaceynxoex(ljvbjrajbd) = huhtepwvel hagnhjfdkh (etxaouynuy, 26.7 ~ 37.8) View more |